CD274 and non-small cell lung carcinoma: ORR, as measured by various PD-L1 measurements, ranged from 37.9% (IHC < 1% TPS) to 72.7% (RNA-seq high) for melanoma, 11.9% (RNA-seq low) to 42.1% (IHC > 50% TPS) for NSCLC, and 8.3% (RNA-seq low) to 40.0% (IHC > 1% TPS) for RCC.